2024
NCCN Guidelines® Insights: Survivorship, Version 2.2024.
Sanft T, Day A, Goldman M, Ansbaugh S, Armenian S, Baker K, Ballinger T, Demark-Wahnefried W, Fairman N, Feliciano J, Flores T, Friedman D, Gabel N, Hill-Kayser C, Koura D, Lee K, Lee N, McDonough A, Melisko M, Mooney K, Moore H, Moryl N, Neuman H, Overholser L, Patel C, Peterson L, Pirl W, Porpiglia A, Schapira L, Schwartz A, Smith S, Tevaarwerk A, Von Ah D, Wake R, Yang E, Zee P, McMillian N, Freedman-Cass D. NCCN Guidelines® Insights: Survivorship, Version 2.2024. Journal Of The National Comprehensive Cancer Network 2024, 22: 648-658. PMID: 39689426, DOI: 10.6004/jnccn.2024.0062.Peer-Reviewed Original Research
2023
NCCN Guidelines® Insights: Survivorship, Version 1.2023.
Sanft T, Day A, Ansbaugh S, Armenian S, Baker K, Ballinger T, Demark-Wahnefried W, Dickinson K, Fairman N, Felciano J, Flores T, Friedman D, Gabel N, Goldman M, Henry N, Hill-Kayser C, Hudson M, Koura D, Lee K, McDonough A, Melisko M, Mooney K, Moore H, Moryl N, Neuman H, O'Connor T, Overholser L, Paskett E, Patel C, Peterson L, Pirl W, Porpiglia A, Rodriguez M, Schapira L, Schwartz A, Smith S, Tevaarwerk A, Yang E, Zee P, McMillian N, Freedman-Cass D. NCCN Guidelines® Insights: Survivorship, Version 1.2023. Journal Of The National Comprehensive Cancer Network 2023, 21: 792-803. PMID: 37549906, DOI: 10.6004/jnccn.2023.0041.Peer-Reviewed Original ResearchConceptsCancer survivorsCognitive functionNCCN guidelinesHealthy behaviorsNCCN Guidelines InsightsAdult-onset cancersSleep disordersRecent guideline updatesVaried needsGuideline updateTreatment recommendationsCare coordinationSurvivorsPhysical problemsDisordersGuidelinesProfessionalsImmunizationCancerSurvivorshipBehaviorRecommendationsA review of the impact of energy balance on triple-negative breast cancer
Akingbesote N, Owusu D, Liu R, Cartmel B, Ferrucci L, Zupa M, Lustberg M, Sanft T, Blenman K, Irwin M, Perry R. A review of the impact of energy balance on triple-negative breast cancer. JNCI Monographs 2023, 2023: 104-124. PMID: 37139977, DOI: 10.1093/jncimonographs/lgad011.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsTriple-negative breast cancerInterventional studyBreast cancerCancer treatmentClinical interventional studyClinical observationalImmune activationCancer outcomesCancer careClinical studiesOverall healthEnergy intakeNarrative reviewCancer cellsEnergy expenditureCancerTreatmentEnergy balanceOutcomesExerciseReviewDetrimental effectsImmunotherapyStudyIntakeAntibiotic therapy is associated with adverse drug events among older adults with advanced cancer: A cohort study
Datta R, Han L, Doyle M, Allore H, Sanft T, Quagliarello V, Juthani-Mehta M. Antibiotic therapy is associated with adverse drug events among older adults with advanced cancer: A cohort study. Palliative Medicine 2023, 37: 793-798. PMID: 36999898, DOI: 10.1177/02692163231162889.Peer-Reviewed Original ResearchConceptsAdverse drug eventsAntibiotic therapyDrug eventsAdvanced cancerOlder adultsIndex admissionPalliative chemotherapyCohort studyTertiary care centerHospitalized older adultsPalliative care providersMultidrug-resistant organismsMean ageCommon tumorsCare centerCare providersRatio of daysSolid tumorsMultivariable testingPatientsTherapyStandardized criteriaCancerMean timeAdultsA qualitative study identifying challenges resulting from complex evidence on lifestyle factors and cancer: perspectives from Black and Latina cancer survivors and healthcare providers
Pichardo M, Irwin M, Sanft T, Ferrucci L, Ginader A, Nguyen T, Esserman D, Cartmel B, Molina Y. A qualitative study identifying challenges resulting from complex evidence on lifestyle factors and cancer: perspectives from Black and Latina cancer survivors and healthcare providers. Supportive Care In Cancer 2023, 31: 111. PMID: 36633678, PMCID: PMC9912693, DOI: 10.1007/s00520-022-07539-9.Peer-Reviewed Original ResearchConceptsBreast cancer survivorsOncology healthcare providersCancer survivorsLifestyle behaviorsHealthcare providersGeneric messagingEvidence-based knowledgeFemale breast cancer survivorsHealthcare provider counselingHealthy lifestyle guidelinesPatient-level barriersHealthy lifestyle behaviorsLifestyle guidelinesProvider counselingLifestyle factorsOncology careCancer outcomesBreast cancerConsistency of evidenceCurrent evidenceAvailable evidenceSurvivorsCancer diagnosisLevel barriersCancer
2022
NCCN Guidelines® Insights: Survivorship, Version 1.2022.
Sanft T, Day A, Peterson L, Rodriguez MA, Ansbaugh S, Armenian S, Baker KS, Ballinger T, Broderick G, Demark-Wahnefried W, Dickinson K, Fairman NP, Friedman DL, Goldman M, Henry NL, Hill-Kayser C, Hudson M, Khakpour N, Koura D, McDonough AL, Melisko M, Mooney K, Moore HCF, Moryl N, Neuman H, O'Connor T, Overholser L, Paskett ED, Patel C, Pirl W, Porpiglia A, Ruddy KJ, Schapira L, Shockney L, Smith S, Syrjala KL, Tevaarwerk A, Yang EH, Zee P, McMillian NR, Freedman-Cass DA. NCCN Guidelines® Insights: Survivorship, Version 1.2022. Journal Of The National Comprehensive Cancer Network 2022, 20: 1080-1090. PMID: 36240847, DOI: 10.6004/jnccn.2022.0052.Peer-Reviewed Original Research
2020
Education needed to improve antimicrobial use during end-of-life care of older adults with advanced cancer: A cross-sectional survey
Datta R, Topal J, McManus D, Sanft T, Dembry LM, Morrison LJ, Quagliarello V, Juthani-Mehta M. Education needed to improve antimicrobial use during end-of-life care of older adults with advanced cancer: A cross-sectional survey. Palliative Medicine 2020, 35: 236-241. PMID: 32928066, DOI: 10.1177/0269216320956811.Peer-Reviewed Original ResearchConceptsEscalation of careAdvance care planningLife careAdvanced cancerCross-sectional surveyIntravenous antimicrobialsOlder adultsAntimicrobial useCare planningSingle-center cross-sectional surveyEducational interventionAdvance care plansRole of antimicrobialsClinical deteriorationPercent of respondentsAdverse eventsOral antimicrobialsMedicine subspecialistsCare plansInpatient medicineCareCancerPatientsAdultsSubspecialists
2018
84 Psychosocial Consequences and Lifestyle Interventions
Mehra K, Berkowitz A, Sanft T. 84 Psychosocial Consequences and Lifestyle Interventions. 2018, 1039-1048.e4. DOI: 10.1016/b978-0-323-35955-9.00084-2.Peer-Reviewed Original ResearchLifestyle interventionBreast cancerBreast cancer patientsBreast cancer riskLives of patientsLifestyle factorsCancer patientsInterventional studyCancer riskPsychosocial interventionsPsychosocial consequencesSignificant distressPatientsCancerInterventionOverview of optionsDiseaseDistressRiskPainPrognosisArea of investigationDiagnosisSurvivorsWomen
2016
Recent Updates in the Management of Triple Negative Breast Cancer
Sanft T, Moran M. Recent Updates in the Management of Triple Negative Breast Cancer. TouchREVIEWS In Oncology & Haematology 2016, 12: 36. DOI: 10.17925/ohr.2016.12.01.36.Peer-Reviewed Original ResearchTriple-negative breast cancerNegative breast cancerBreast cancerLocoregional treatment optionsComplete pathologic responseNeoadjuvant chemotherapyPathologic responseResidual diseaseTreatment optionsAggressive subtypeNew agentsCancerDruggable targetsDisease biologyRecent updatesFurther researchChemotherapyPatientsTherapySubtypesDisease
2015
Prospective study of the decision-making impact of the Breast Cancer Index in the selection of patients with ER+ breast cancer for extended endocrine therapy.
Sanft T, Aktas B, Schroeder B, Bossuyt V, DiGiovanna M, Abu-Khalaf M, Chung G, Silber A, Hofstatter E, Mougalian S, Epstein L, Hatzis C, Schnabel C, Pusztai L. Prospective study of the decision-making impact of the Breast Cancer Index in the selection of patients with ER+ breast cancer for extended endocrine therapy. Journal Of Clinical Oncology 2015, 33: 538-538. DOI: 10.1200/jco.2015.33.15_suppl.538.Peer-Reviewed Original Research
2014
Cardiac outcomes in women receiving aromatase inhibitors as adjuvant endocrine therapy for breast cancer.
Park E, Abu-Khalaf M, Hatzis C, LaSala J, Silber A, Hofstatter E, Sanft T, Russell R. Cardiac outcomes in women receiving aromatase inhibitors as adjuvant endocrine therapy for breast cancer. Journal Of Clinical Oncology 2014, 32: e11501-e11501. DOI: 10.1200/jco.2014.32.15_suppl.e11501.Peer-Reviewed Original Research